Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1196777 | 1.00 | ATM (0.46) | ATMHCAR2ALDH1A1TSHRHPGD | |
| SCHEMBL1196078 | 1.00 | ATM (0.46) | ATMHCAR2ALDH1A1TSHRHPGD | |
| SCHEMBL3960625 | 0.93 | HCAR2 (0.47) | HCAR2TSHRGPR84TP53FFAR1 | |
| SCHEMBL8935618 | 0.91 | HCAR2 (0.48) | HCAR2ALDH1A1TSHRGPR84TP53 | |
| SCHEMBL712622 | 0.91 | HCAR2 (0.48) | HCAR2ALDH1A1TSHRGPR84TP53 | |
| SCHEMBL5718514 | 0.91 | HCAR2 (0.48) | HCAR2ALDH1A1TSHRGPR84TP53 | |
| SCHEMBL7652872 | 0.91 | HCAR2 (0.48) | HCAR2ALDH1A1TSHRGPR84TP53 | |
| SCHEMBL453154 | 0.91 | HCAR2 (0.48) | HCAR2ALDH1A1TSHRGPR84TP53 | |
| SCHEMBL28253693 | 0.91 | HCAR2 (0.48) | HCAR2ALDH1A1TSHRGPR84TP53 | |
| SCHEMBL27575401 | 0.91 | HCAR2 (0.48) | HCAR2ALDH1A1TSHRGPR84TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 614 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108135210-A | Highly uniform hydrophilic chewing gum base | WM.雷格利JR.公司 | 2018-06-08 | — | — | CN | claimed |
| US-9149439-B2 | Multi-particulate, modified-release composition | SANDOZ AG (CH) | 2015-10-06 | — | — | US | claimed |
| WO-2014029953-A1 | HOT MELT EXTRUDED (HME) PHARMACEUTICAL COMPOSITION OF CINACALCET | CIPLA LIMITED (IN) | 2014-02-27 | — | — | WO | claimed |
| US-8168228-B2 | Oral micropellets containing an antibiotic having an inner coating of a cellulose polymer (not enteric)and an outer coating of an enteric coating polymer; particle size of 100 to 650 mu m.; lack of bitter taste; fast dissolution; increased antibiotic bioavailability compared pellets having a matrix | SANDOZ AG (CH) | 2012-05-01 | — | — | US | claimed |
| US-20100179210-A1 | NOVEL ENANTIOMERICALLY PURE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | Piramal Enterprises Limited (IN) | 2010-07-15 | — | — | US | claimed |
| US-20100173921-A1 | Antiretroviral Solid Oral Composition | CIPLA LIMITED (IN) | 2010-07-08 | — | — | US | claimed |
| EP-1215305-B1 | Method for preparing an electroplating bath and related copper plating process | IMEC (BE) | 2010-05-05 | — | — | EP | claimed |
| EP-2046738-A1 | ENANTIOMERICALLY PURE FLAVONE DERIVATIVES FOR THE TREATMENT OF POLIFERATIVE DISORDERS AND PROCESSES FOR THEIR PREPARATION | Piramal Life Sciences Limited (IN) | 2009-04-15 | — | — | EP | claimed |
| EP-1680088-B1 | Taste-masked formulation comprising clarithromycin | SANDOZ AG (CH) | 2008-12-03 | — | — | EP | claimed |
| WO-2008017867-A2 | ANTIRETROVIRAL SOLID ORAL COMPOSITION WITH AT LEAST ONE WATER INSOLUBLE POLYMER | CIPLA LIMITED (IN) | 2008-02-14 | — | — | WO | claimed |
| EP-1680088-A1 | ANTIBIOTIC COMPOSITIONS | Sandoz AG (CH) | 2006-07-19 | — | — | EP | claimed |
| US-20050181052-A1 | Lansoprazole microtablets | PATEL SATISHKUMAR A (US) | 2005-08-18 | — | — | US | claimed |
| WO-2005039536-A1 | ANTIBIOTIC COMPOSITIONS | SANDOZ AG (CH) | 2005-05-06 | — | — | WO | claimed |
| US-20050084541-A1 | Antibiotic compositions | SANDOZ, AG (CH) | 2005-04-21 | — | — | US | claimed |
| US-6872295-B2 | Method for preparing an electroplating bath and related copper plating process | INTERUNIVERSITAIR MICROELEKTRONICA CENTRUM (IMEC) (BE) | 2005-03-29 | — | — | US | claimed |
| US-20020153259-A1 | Method for preparing an electroplating bath and related copper plating process | INTERUNIVERSITAIR MICROELEKTRONICA CENTRUM (IMEC) (BE) | 2002-10-24 | — | — | US | claimed |
| EP-1215305-A1 | Method for preparing an electroplating bath and related copper plating process | INTERUNIVERSITAIR MICRO-ELEKTRONICA CENTRUM VZW (BE) | 2002-06-19 | — | — | EP | claimed |
| EP-0894490-B1 | Cosmetic compositions comprising a film-forming polymer | OREAL (FR) | 2002-01-16 | — | — | EP | claimed |
| EP-0951905-A2 | Pharmaceutical compositions for programmed therapeutical coverage | APR APPLIED PHARMA RESEARCH S.A. (CH) | 1999-10-27 | — | — | EP | claimed |
| US-4151102-A | POLYISOBUTYLENE, ESTER OF ALPHA-HYDROXY ACID, UNSATURATED ACID | SWISS ALUMINIUM LTD. (CH) | 1979-04-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179210-A1 | NOVEL ENANTIOMERICALLY PURE COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | CDK2, CDK9, CDK1 | ATM 917/4885HCAR2 3243/4885ALDH1A1 1497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.